Trials / Sponsors / ProDa BioTech, LLC
ProDa BioTech, LLC
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2024-08-20 |
| Recruiting | ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1 | 2023-09-14 |
| Active Not Recruiting | ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies Advanced Pancreatic Cancer, Solid Tumor Malignancies | Phase 1 | 2021-10-29 |